Market Survey on Anemia Treatment Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Anemia Treatment Market including Medications, and Dietary Supplements Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
[257 Pages Report] Sales in the global anemia treatment market are slated to top US$ 10.0 Billion in 2022. With sales growing at a healthy 6.9% CAGR, the market size is projected to total US$ 14.9 Billion by 2028.
Attribute
Details
Anemia Treatment Market Estimated Size 2022
US$ 10.0 Billion
Anemia Treatment Market Value-based CAGR (2022 to 2028)
~ 6.9%
Anemia Treatment Market Size in Projected 2028
US$ 14.9 Billion
Ongoing development of enhanced distribution channels and new manufacturing hubs by key players in emerging economies, such as Brazil, India, and China is expected to boost the market. The rising number of pipelines for acute anemia treatment drugs worldwide will continue augmenting the growth in the market.
The high rate of nutritional deficiency owing to the consumption of alcohol and tobacco is driving sales of aplastic anemia treatment drugs. The increasing prevalence of chronic diseases and improper nutritional diet, especially in underdeveloped countries will spur demand in the market over the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
7.60%
H1, 2022 Projected
6.87%
H1, 2022 Outlook
5.37%
BPS Change - H1, 2022 (O) – H1, 2022 (P)
(-) 150 ↓
BPS Change – H1, 2022 (O) – H1, 2021
(-) 223 ↓
The comparative analysis and market growth rate of the global anaemia treatment market as studied by Future Market Insights will show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 150 BPS. A decline in BPS growth is expected in H1-2022 over H1- 2021 duration with 223 Basis Point Share (BPS).
The market is subject to changes due to new drug approvals, growing disease prevalence, a rise in lifestyle-associated concerns, and technological advancements.
In order to eliminate the medical problem among women working in manual labour, pharmaceutical companies are running iron supplementation programmes. However, low supplement compliance, latent symptoms, and a lack of programme monitoring impede market expansion. This is associated with the reduction in the BPS values for the market.
Furthermore, the market is highly influenced by the recent boost in pharmaceutical production facilities and growing R&D activities for disease therapeutics. Key developments in the market include the emergence of new pharmacological anti-sickling approaches, gene therapies, and advances in haematopoietic stem cell transplantation.
2013-2021 Anemia Treatment Market Outlook in Comparison to 2022-2028 Growth Forecast
The anemia treatment market is expected to register a 6.9% CAGR between 2022 and 2028, up from the 7.3% CAGR recorded during 2013-2021, projects Future Market Insights.
Rising investments in research and development activities by key drug manufacturers to develop and distribute therapeutically effective medicaments, such as chelating agents, antibiotics, ESAs, and dietary supplements will drive the market.
Players are also focusing on the introduction of novel drugs for aplastic anemia treatment that would help in providing superior-quality healthcare in emerging economies.
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), it is estimated that more than 1 out of every 7 people with kidney disease suffer from anemia. Spurred by the factors above, the market is likely to showcase rapid growth in the forthcoming years.
How is Rising Incidence of Iron Deficiency Influencing Sales?
The high risk of iron deficiency anemia in pregnant women is expected to propel the sales of novel drugs for iron anemia treatment in the forthcoming years. This mainly happens as the volume of blood increases in the body during pregnancy and the body starts using the iron to make more blood to supply oxygen to the fetus.
The urgent need for iron deficiency anemia treatment options as it can often cause premature births and postpartum depression is expected to boost sales. This condition can also lead to the death of infants immediately before or after birth, also resulting in low birth weight in babies.
Why is the Increasing Geriatric Population Boosting Sales?
The growing geriatric population across the globe is likely to fuel the demand for cutting-edge drugs for iron anemia treatment. Growth is attributable to the inadequate absorption or intake of iron among older people.
Numerous underlying causes, such as the rising prevalence of various chronic ailments, especially infections and cancers among the ageing population are underpinning the need for anemia treatment drugs. As per the World Health Organization (WHO), cancer accounted for about 10 million deaths in 2020 globally. These cases are expected to surge in future, thereby spurring demand in the market.
Find your sweet spots for generating winning opportunities in this market.
Country-wise Insights
What is the U.S. Anemia Treatment Market Outlook?
“Presence of Favorable Reimbursement Policies to Drive Sales of Drugs for Iron Anemia Treatment”
The early adoption of technologically advanced treatment options in the U.S. is a major factor that is expected to boost the market over the forthcoming years. The consistent introduction of favourable reimbursement policies by the government is anticipated to accelerate sales in the U.S. market.
As per the American Family Physician, the prevalence of iron deficiency anemia is about 20% in black and Mexican-American women, 9 to 12% in non-Hispanic white women, and nearly 2% in adult men. Approximately 9% of patients older than 65 years with this condition have gastrointestinal cancer. These numbers are estimated to grow in the near future, thereby propelling the sales of drugs for iron anemia treatment.
How is the U.K. Anemia Treatment Market Progressing?
“Lack of Iron Intake to Propel the Demand for Novel Aplastic Anemia Treatment Options”
The increasing incidence of iron deficiency among individuals in the U.K. will continue driving sales over the forecast period. Innovative technologies and changing lifestyle patterns are other crucial factors expected to drive the demand for drugs for aplastic anemia treatment in the U.K.
Increasing per capita income and the entry of several established companies are leading to the surging number of research and development activities in this country. The rising number of new product launches is also set to augment the growth in the market.
Why is China Anemia Treatment Market Witnessing High Demand?
“Governments are Taking Initiatives to Deliver AffordableAcute Anemia Treatment Drugs”
Various government initiatives to provide cost-effective acute anemia treatment drugs in China will likely augur well for the East Asia market. Rising awareness among people regarding the treatment and diagnosis of this disease is also expected to boost sales.
In November 2020, for instance, researchers from numerous educational institutions based in China conducted a study to evaluate the prevalence of iron deficiency anemia and anemia in pregnant women. Nearly 13.9% of Chinese women were diagnosed with iron deficiency anemia, while around 19.8% were diagnosed with anemia. The increasing number of similar research studies in this country is anticipated to fuel the market.
Category-wise Insights
Which is the Most Preferred Anemia Treatment Option?
“Medications forSickle Cell Anemia Treatment are Exhibiting High Demand”
By treatment, the medications segment is anticipated to dominate the global anemia treatment market. Increasing usage of biologics, such as Erythropoietin Stimulating Agents (ESAs) is likely to propel the sales of medications for sickle cell anemia treatment.
In addition to this, a growing number of FDA approvals for numerous biosimilars is expected to provide various benefits to patients living with the anemia of chronic kidney disease. Easy patient access to unique ESAs and the high demand for cost-effective biosimilar medications are set to create new growth opportunities for key players operating in the market.
Which Disease Segment is Likely to Lead the Anemia Treatment Market?
“Acute Anemia Treatment Options are Demanded by Normocytic Anemia Patients”
Based on disease, sales in the normocytic anemia segment are projected to gain traction over the forecast period. The growing prevalence of congenital disorders, such as sickle cell disease across the globe is set to push demand in the segment.
Other long-term chronic diseases, such as thyroiditis, kidney disease, rheumatoid arthritis, and cancer can also cause normocytic anemia in people. According to the Centers for Disease Control and Prevention (CDC), around 58.5 million adults had some form of arthritis, fibromyalgia, or lupus from 2013 to 2015. Thus, rising cases of various chronic diseases worldwide is projected to boost the need for acute anemia treatment options.
Which Distribution Channel is Most Preferred for Anemia Treatment Drugs?
“Availability of Medications for Sickle Cell Anemia Treatment to Surge Sales from Institutional Pharmacies”
In terms of distribution channel, the institutional pharmacies segment is set to account for nearly 55.9% of the global anemia treatment market share in 2022, finds FMI. The easy availability of a wide range of medications for sickle cell anemia treatment will likely drive the segment over the assessment period.
According to FMI, the retail pharmacies and mail-order pharmacies segments are expected to generate account for 38.0% and 6.1% of the total market share in 2022, respectively. The ability of retail pharmacists to provide customers with personalized advice that would pertain to their specific circumstances and health needs will boost sales. Mail-order pharmacies, on the other hand, are considered to be cost-effective as they eliminate the need to visit pharmacies physically.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Competition Landscape
Leading players operating in the global anemia treatment market are focusing on adopting various marketing strategies to expand their geographical presence and product portfolios. Some of the other key players are striving to join hands with international and local retailers to distribute their in-house acute anemia treatment medications. Meanwhile, a few renowned companies are aiming to develop innovative drugs and gain approval from regulatory bodies for marketing. For instance:
In February 2022, the U.S. Food and Drug Administration (FDA) approved Pyrukynd (mitapivat) tablets for the treatment of hemolytic anemia in adult patients living with Pyruvate Kinase (PK) deficiency. The drug’s effectiveness was evaluated by conducting two studies. In the single-arm study, its effectiveness was examined based on the reduction in transfusion burden, whereas in the randomized study, it was based on the hemoglobin response.
In February 2022, the European Commission approved Global Blood Therapeutics, Inc.’s Oxbryta (voxelotor) to treat hemolytic anemia in patients suffering from sickle cell disease between the age group of 12 years and above. It is the first medicine that was approved in Europe for destroying red blood cells and directly inhibiting the molecular basis of sickling.
Scope of Report
Attribute
Details
Forecast Period
2022 to 2028
Historical Data Available for
2013 to 2021
Market Analysis
Units for Volume and US$ Billion for Value
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa.
Key Countries Covered
The USA, Canada, Brazil, Mexico, Germany, the UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.
Key Market Segments Covered
Treatment, Disease, Distribution Channel, and Region
Key Companies Profiled
Amgen Inc.
Hoffmann-La Roche Ltd.
Novartis AG
Pfizer Inc.
Janssen Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
AMAG Pharmaceuticals
Rockwell Medical
Akebia Therapeutics
Vifor Pharma Management Ltd.
Pricing
Available upon Request
Anemia Treatment Market by Category
By Treatment:
Medications
Dietary Supplements
By Disease:
Normocytic anemia
Microcytic anemia
Macrocytic anemia
By Distribution Channel:
Institutional Pharmacies
Retail Pharmacies
Mail Order Pharmacies
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Frequently Asked Questions
The global anemia treatment market is expected to reach a valuation of US$ 10.0 Bn in 2022.
The global anemia treatment market grew at a healthy 7.3% CAGR between 2013 and 2021.
Rising prevalence of cancer and the increasing demand for biologics are the key trends boosting the sales of anemia treatment solutions.
Amgen Inc., Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., and AMAG Pharmaceuticals are some of the leading players present in the global anemia treatment market.
The retail pharmacies segment is anticipated to account for 38.0% of the anemia treatment market share in 2022.
The mail order pharmacies segment is projected to account for 6.1% of the anemia treatment market share in the forecast period.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Anemia Epidemiology, By Key Countries
3.2. Product Innovation / Key Development Trends
3.3. New Launches and other trends
4. Key Success Factors
4.1. Anemia Diagnosis Trend Analysis
4.2. Global Seeking Rate
4.3. Drug Pipeline Assessment
5. Global Market - Pricing Analysis
5.1. Regional Pricing Analysis By Treatment
5.2. Pricing Break-up
5.2.1. Manufacturer Level Pricing
5.2.2. Distributor Level Pricing
5.3. Global Average Pricing Analysis Benchmark
6. Global Market Analysis 2013-2021 and Forecast, 2022-2028
6.1. Historical Market Value (US$ Mn) Analysis, 2013-2021
6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2028
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.1.1. Gross Domestic Product by Region & Country, 2006 – 2021
7.1.2. Global Healthcare Expenditure Outlook
7.2. Forecast Factors - Relevance & Impact
7.2.1. Anemia Prevalence and Growth
7.2.2. Per-Capita Healthcare Expenditure
7.2.3. Treatment Seeking Rate
7.2.4. Prescription Rate and Drug Penetration
7.2.5. Per Patient Spending
7.3. Value Chain
7.4. Market Dynamics
7.4.1. Drivers
7.4.2. Restraints
7.4.3. Opportunity Analysis
8. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Treatment Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Treatment, 2013 - 2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment, 2022 - 2028
8.3.1. Microcytic Anemia (Low MCV)
8.3.1.1. Iron deficiency anemia
8.3.1.2. Thalassemia
8.3.1.3. Sideroblastic anemia
8.3.2. Normocytic Anemia (Normal MCV)
8.3.2.1. Blood loss Anemia
8.3.2.2. Sickle cell anemia
8.3.2.3. Anemia due to chronic disease
8.3.2.4. Aplastic Anemia
8.3.3. Macrocytic Anemia (High MCV)
8.3.3.1. Vitamin deficiency anemia
8.4. Market Attractiveness Analysis By Treatment
9. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Disease Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Disease Type, 2013 - 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2022 - 2028
9.3.1. Microcytic Anemia (Low MCV)
9.3.1.1. Iron deficiency Anemia
9.3.1.2. Thalassemia
9.3.1.3. Sideroblastic Anemia
9.3.2. Normocytic Anemia (Normal MCV)
9.3.2.1. Blood loss Anemia
9.3.2.2. Sickle cell anemia
9.3.2.3. Anemia due to Chronic disease
9.3.2.4. Aplastic Anemia
9.3.3. Macrocytic Anemia (High MCV)
9.3.3.1. Vitamin deficiency Anemia
9.4. Market Attractiveness Analysis By Disease Type
10. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Route of Administration
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2013 - 2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration 2022 – 2028
10.3.1. Oral Route
10.3.2. Injectable Route
10.4. Market Attractiveness Analysis By Route of Administration
11. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013 - 2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Distribution Channel 2022 – 2028
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Mail-order Pharmacies
11.4. Market Attractiveness Analysis By Distribution Channel
12. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 - 2021
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2022
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Middle East and Africa (MEA)
12.3.5. East Asia
12.3.6. South Asia
12.3.7. Oceania
12.4. Market Attractiveness Analysis By Region13. North America Market Analysis 2013-2021 and Forecast 2022-2028
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
13.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.2. By Treatment Type
13.4.3. By Distribution Channel
13.5. Market Attractiveness Analysis
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
14. Latin America Market Analysis 2013-2021 and Forecast 2022-2028
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
14.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Argentina
14.4.1.4. Rest of Latin America
14.4.2. By Treatment Type
14.4.3. By Distribution Channel
14.5. Market Attractiveness Analysis
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
15. Europe Market Analysis 2013-2021 and Forecast 2022-2028
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
15.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. Italy
15.4.1.3. France
15.4.1.4. U.K.
15.4.1.5. Spain
15.4.1.6. BENELUX
15.4.1.7. Russia
15.4.1.8. Rest of Europe
15.4.2. By Treatment Type
15.4.3. By Distribution Channel
15.5. Market Attractiveness Analysis
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
16. East Asia Market Analysis 2013-2021 and Forecast 2022-2028
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.2. By Treatment Type
16.4.3. By Distribution Channel
16.5.Market Attractiveness Analysis
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2013-2021 and Forecast 2022-2028
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
17.4.1. By Country
17.4.1.1. India
17.4.1.2. Thailand
17.4.1.3. Indonesia
17.4.1.4. Malaysia
17.4.1.5. Rest of South Asia
17.4.2. By Treatment Type
17.4.3. By Distribution Channel
17.5. Market Attractiveness Analysis
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Oceania Market Analysis 2013-2021 and Forecast 2022-2028
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
18.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
18.4.1. By Country
18.4.1.1. Australia
18.4.1.2. New Zealand
18.4.2. By Treatment Type
18.4.3. By Distribution Channel
18.5. Market Attractiveness Analysis
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Market Analysis 2013-2021 and Forecast 2022-2028
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
19.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
19.4.1. By Country
19.4.1.1. GCC Countries
19.4.1.2. South Africa
19.4.1.3. Rest of Middle East and Africa
19.4.2. By Treatment Type
19.4.3. By Distribution Channel
19.5. Market Attractiveness Analysis
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
20. Emerging Countries Market Analysis 2013-2021 and Forecast 2022-2028
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. China Market Analysis
20.2.1. Introduction
20.2.2. Market Value Proportion Analysis by Market Taxonomy
20.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.2.3.1. By Treatment Type
20.2.3.2. By Distribution Channel
20.2.4. China Market - Competition Landscape
20.3. India Market Analysis
20.3.1. Introduction
20.3.2. Market Value Proportion Analysis by Market Taxonomy
20.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.3.3.1. By Treatment Type
20.3.3.2. By Distribution Channel
20.3.4. India Market - Competition Landscape
20.4. Brazil Market Analysis
20.4.1. Introduction
20.4.2. Market Value Proportion Analysis by Market Taxonomy
20.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.4.3.1. By Treatment Type
20.4.3.2. By Distribution Channel
20.4.4. Brazil Treatment Market - Competition Landscape
21. Competition Analysis
21.1. Competition Dashboard
21.2. Pricing Analysis by Competition
21.3. Competition Benchmarking
21.4. Competition Deep Dive
21.4.1. Amgen Inc
21.4.1.1. Overview
21.4.1.2. Product Portfolio
21.4.1.3. Sales Footprint
21.4.1.4. Analyst commentary
21.4.2. Hoffmann-La Roche Ltd
21.4.3. Novartis AG
21.4.4. Pfizer Inc
21.4.5. Janssen Pharmaceuticals, Inc.
21.4.6. Teva Pharmaceutical Industries Ltd,
21.4.7. AMAG Pharmaceuticals
21.4.8. Rockwell Medical
21.4.9. Akebia Therapeutics
21.4.10. Vifor Pharma Management Ltd.
22. Assumptions and Acronyms Used23. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market, Key Developments (2007-2019)
Table 2: Market Pipeline Analysis (2021)
Table 3: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 4: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 5: Global Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Type
Table 6: Global Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 7: Global Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 8: Global Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 9: Global Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region
Table 10: North America Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 11: North America Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Type
Table 12: North America Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 13: North America Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 14: North America Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 15: Latin America Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 16: Latin America Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Type
Table 17: Latin America Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 18: Latin America Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 19: Latin America Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 20: Europe Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 21: Europe Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Type
Table 22: Europe Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 23: Europe Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 24: Europe Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 25: East Asia Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 26: East Asia Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Type
Table 27: East Asia Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 28: East Asia Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 29: East Asia Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 30: South Asia Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 31: South Asia Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Type
Table 32: South Asia Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 33: South Asia Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 34: South Asia Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 35: Oceania Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 36: Oceania Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Type
Table 37: Oceania Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 38: Oceania Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 39: Oceania Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 40: MEA Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 41: MEA Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Type
Table 42: MEA Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 43: MEA Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 44: MEA Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 45: Emerging Market Value Proportion Analysis 2013-2021 and Forecast 2022-2028, By Countr45
Table 46: Emerging and Global Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028
Table 47: China Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Type
Table 48: China Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 49: China Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 50: China Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 51: Brazil Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Type
Table 52: Brazil Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 53: Brazil Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 54: Brazil Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 55: India Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Type
Table 56: India Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 57: India Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 58: India Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: World Anemic Population by Key Countries, 2021 (Unit)
Figure 02: World Diagnosed Anemic Population by Key Countries, 2021 (Unit)
Figure 03: World Anemic Treatment Seeking Rate (%), by Key Countries, 207
Figure 04: Distribution of Industry Sponsored Clinical Programs, by Phase
Figure 05: Number of Clinical Programs (phase II | phase III & phase III) expected to be completed by 2020, by company
Figure 06: Global Iron Supplements Market, Price Difference (US$) By Region, 2021
Figure 07: Global Iron Supplements Market, Price Difference (US$) By Region, 2028
Figure 08: Global Vitamin Supplements Market, Price Difference (US$) By Region, 2021
Figure 09: Global Vitamin Supplements Market, Price Difference (US$) By Region, 2028
Figure 10: Global Red Blood Cell Transfusions Market, Price Difference (US$) By Region, 2021
Figure 11: Global Red Blood Cell Transfusions Market, Price Difference (US$) By Region, 2028
Figure 12: Global Erythropoietin-stimulating agents (ESAs) Market, Price Difference (US$) By Region, 2021
Figure 13: Global Erythropoietin-stimulating agents (ESAs) Market, Price Difference (US$) By Region, 2028
Figure 14: Global Chelation therapy Market, Price Difference (US$) By Region, 2021
Figure 15: Global Chelation therapy Market, Price Difference (US$) By Region, 2028
Figure 16: Global Antibiotics Market, Price Difference (US$) By Region, 2021
Figure 17: Global Antibiotics Market, Price Difference (US$) By Region, 2028
Figure 18: Global Market Historical Market Value (US$ Mn) Analysis, 2013-2021
Figure 19: Global Current and Future Market Value (US$ Mn), 2022-2028 & Y-o-Y Growth Trend Analysis
Figure 20: Market Absolute $ Opportunity, 2013–2028
Figure 21: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 22: Global Market Attractiveness Analysis, By Treatment
Figure 23: Global Market Attractiveness Analysis, By Disease Type
Figure 24: Global Market Attractiveness Analysis, By Route of Administration
Figure 25: Global Market Attractiveness Analysis, Distribution Channel
Figure 26: Global Market Attractiveness Analysis, Region
Figure 27: North America Market Value (US$ Mn) Analysis, 2013–2021
Figure 28: North America Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2028
Figure 29: U.S. Market Value (US$ Mn) Analysis, 2013-2021
Figure 30: U.S. Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 31: Canada Systems Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 32: Canada Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 33: North America Market Attractiveness Analysis, By Treatment Type
Figure 34: North America Market Attractiveness Analysis, By Disease Type
Figure 35: North America Market Attractiveness Analysis, By Route of Administration
Figure 36: North America Market Attractiveness Analysis, By Distribution Channel
Figure 37: North America Brain Monitoring Systems Market Attractiveness Analysis, By Country
Figure 38: Latin America Market Value (US$ Mn) Analysis, 2013–2021
Figure 39: Latin America Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2028
Figure 40: Brazil Market Value (US$ Mn) Analysis, 2013-2021
Figure 41: Brazil Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 42: Mexico Systems Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 43: Mexico Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 44: Argentina Market Value (US$ Mn) Analysis, 2013-2021
Figure 45: Argentina Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 46: Rest of L.A. Systems Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 47: Rest of L.A. Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 48: Latin America Market Attractiveness Analysis, By Treatment Type
Figure 49: Latin America Market Attractiveness Analysis, By Disease Type
Figure 50: Latin America Market Attractiveness Analysis, By Route of Administration
Figure 51: Latin America Market Attractiveness Analysis, By Distribution Channel
Figure 52: Latin America Brain Monitoring Systems Market Attractiveness Analysis, By Country
Figure 53: Europe Market Value (US$ Mn) Analysis, 2013–2021
Figure 54: Europe Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2028
Figure 55: U.K. Market Value (US$ Mn) Analysis, 2013-2021
Figure 56: U.K. Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 57: Germany Systems Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 58: Germany Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 59: France Market Value (US$ Mn) Analysis, 2013-2021
Figure 60: France Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 61: Spain Systems Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 62: Spain Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 63: Italy Market Value (US$ Mn) Analysis, 2013-2021
Figure 64: Italy Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 65: Russia Systems Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 66: Russia Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 67: Rest of Europe Market Value (US$ Mn) Analysis, 2013-2021
Figure 68: Rest of Europe Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 69: Europe Market Attractiveness Analysis, By Treatment Type
Figure 70: Europe Market Attractiveness Analysis, By Disease Type
Figure 71: Europe Market Attractiveness Analysis, By Route of Administration
Figure 72: Europe Market Attractiveness Analysis, By Distribution Channel
Figure 73: Europe Brain Monitoring Systems Market Attractiveness Analysis, By Country
Figure 74: East Asia Market Value (US$ Mn) Analysis, 2013–2021
Figure 75: East Asia Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2028
Figure 76: Japan Market Value (US$ Mn) Analysis, 2013-2021
Figure 77: Japan Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 78: South Korea Systems Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 79: South Korea Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 80: China Market Value (US$ Mn) Analysis, 2013-2021
Figure 81: China Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 82: East Asia Market Attractiveness Analysis, By Treatment Type
Figure 83: East Asia Market Attractiveness Analysis, By Disease Type
Figure 84: East Asia Market Attractiveness Analysis, By Route of Administration
Figure 85: East Asia Market Attractiveness Analysis, By Distribution Channel
Figure 86: East Asia Brain Monitoring Systems Market Attractiveness Analysis, By Country
Figure 87: South Asia Market Value (US$ Mn) Analysis, 2013–2021
Figure 88: South Asia Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2028
Figure 89: Thailand Market Value (US$ Mn) Analysis, 2013-2021
Figure 90: Thailand Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 91: Malaysia Systems Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 92: Malaysia Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 93: Indonesia Market Value (US$ Mn) Analysis, 2013-2021
Figure 94: Indonesia Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 95: Rest of South Asia Systems Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 96: Rest of South Asia Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 97: India Market Value (US$ Mn) Analysis, 2013-2021
Figure 98: India Market Value (US$ Mn) Analysis, 2013-2021
Figure 99: South Asia Market Attractiveness Analysis, By Treatment Type
Figure 100: South Asia Market Attractiveness Analysis, By Disease Type
Figure 101: South Asia Market Attractiveness Analysis, By Route of Administration
Figure 102: South Asia Market Attractiveness Analysis, By Distribution Channel
Figure 103: South Asia Brain Monitoring Systems Market Attractiveness Analysis, By Country
Figure 104: Oceania Market Value (US$ Mn) Analysis, 2013–2021
Figure 105: Oceania Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2028
Figure 106: Australia Market Value (US$ Mn) Analysis, 2013-2021
Figure 107: Australia Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 108: New Zealand o Systems Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 109: New Zealand Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 110: Oceania Market Attractiveness Analysis, By Treatment Type
Figure 111: Oceania Market Attractiveness Analysis, By Disease Type
Figure 112: Oceania Market Attractiveness Analysis, By Route of Administration
Figure 113: Oceania Market Attractiveness Analysis, By Distribution Channel
Figure 114: Oceania Brain Monitoring Systems Market Attractiveness Analysis, By Country
Figure 115: MEA Market Value (US$ Mn) Analysis, 2013–2021
Figure 116: MEA Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2028
Figure 117: GCC Countries Market Value (US$ Mn) Analysis, 2013-2021
Figure 118: GC Countries Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 119: South Africa Systems Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 120: South Africa Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 121: Rest of MEA Market Value (US$ Mn) Analysis, 2013-2021
Figure 122: Rest of MEA Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028
Figure 123: MEA Market Attractiveness Analysis, By Treatment Type
Figure 124: MEA Market Attractiveness Analysis, By Disease Type
Figure 125: MEA Market Attractiveness Analysis, By Route of Administration
Figure 126: MEA Market Attractiveness Analysis, By Distribution Channel
Figure 127: MEA Brain Monitoring Systems Market Attractiveness Analysis, By Country
Figure 128: Global Vs. Emerging Market Value (%) Analysis 2013-2021 and Forecast 2022-2028
Figure 129: China Market Value (US$ Mn) Analysis, 2013–2021
Figure 130: China Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2028
Figure 131: Brazil Market Value (US$ Mn) Analysis, 2013–2021
Figure 132: Brazil Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2028
Figure 133: India Market Value (US$ Mn) Analysis, 2013–2021
Figure 134: India Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2028
